Aspirin-Exacerbated Respiratory Disease II: New Clinical Insights and Treatments
Friday, March 3, 2017: 10:00 AM-12:30 PM
Georgia World Congress Center, Building B, Level 5, Thomas B. Murphy Ballroom 3-4
2.50 CME/CE
Andrew A. White , MD FAAAAI

Learning Objectives:
  1. Describe the efficacy of targeting IgE in AERD and how anti-IgE may work in a non-allergen-driven disease
  2. Discuss AERD in underserved populations
  3. Identify the efficacy of anti-platelet therapy in AERD
10:00 AM
An Informatic Approach to the Diagnosis of AERD
Katherine N. Cahill, MD
10:20 AM
Question & Answer
10:25 AM
Racial Disparities in AERD
Elina Jerschow, MD FAAAAI
10:45 AM
Question & Answer
10:50 AM
Anti-IL-5 as a Treatment for AERD
Marek L. Kowalski, MD PhD
11:10 AM
Question & Answer
11:15 AM
Anti-IgE (Omalizumab) as a Treatment for Severe AERD: Potential Mechanisms
Masami Taniguchi, MD PhD
11:35 AM
Question & Answer
11:40 AM
Results of a Randomized, Double-Blinded Placebo-Controlled Trial of Prasugrel for the Treatment of AERD
Tanya M. Laidlaw, MD FAAAAI
12:00 PM
Question & Answer
12:05 PM
Influence of Inhaled Leukotriene E4 on Airway Caliber and Airway Inflammation in Asthma
Barbro Dahlen, MD PhD
12:25 PM
Question & Answer
See more of: Session